Effects of constant intravenous infusion of detomidine alone or combined with butorphanol or methadone for standing sedation in horses: A randomized clinical trial.
Authors: Júnior G S, de Souza J V, de Souza Ferreira W, Florentino V R D, Valente T C, Comassetto F, Oleskovicz N
Journal: Journal of equine veterinary science
Summary
# Editorial Summary Achieving adequate sedation for standing dental work remains challenging in equine practice, prompting researchers to evaluate whether combining opioids with detomidine could improve efficacy whilst reducing alpha-2 agonist dosing. This randomised, blinded clinical trial enrolled 24 horses undergoing dental occlusal adjustment, comparing three sedation protocols: detomidine alone (DT), detomidine with butorphanol (DB), or detomidine with methadone (DM), all delivered via initial bolus followed by constant rate infusion. Notably, the DM combination required substantially fewer rescue doses (only 2 compared to 8 in DT and 12 in DB), ultimately necessitating total detomidine consumption of just 10.6 μg/kg/h versus 22.4 μg/kg/h in the DT group—a clinically significant reduction. Whilst all protocols reduced heart rate and gastrointestinal motility as expected, the DM group additionally showed decreased respiratory rate, with transient blood pressure elevations occurring across all treatments. For practitioners seeking more reliable standing sedation with lower alpha-2 agonist exposure and reduced rescue requirement burden, incorporating methadone appears substantially more effective than butorphanol, though the modest decreases in respiratory parameters warrant monitoring in individual cases.
Read the full abstract on PubMed
Practical Takeaways
- •Adding methadone to detomidine for standing dental work significantly reduces the amount of detomidine needed while improving sedation reliability and reducing rescue interventions
- •If using opioid combinations for equine dental sedation, methadone appears superior to butorphanol in sparing detomidine dose and requiring fewer top-ups during procedures
- •Monitor for gastrointestinal motility reduction and transient blood pressure changes with all three protocols; respiratory rate monitoring is particularly important with methadone combinations
Key Findings
- •Detomidine-methadone combination required only 10.6 ± 2.32 µg/kg/h total detomidine versus 22.4 ± 4.1 µg/kg/h for detomidine alone, demonstrating a 53% dose reduction
- •Detomidine-butorphanol combination required 13.6 ± 4.58 µg/kg/h total detomidine, achieving a 39% dose reduction compared to detomidine monotherapy
- •Methadone combination required only 2 sedation rescues versus 8 for detomidine alone and 12 for butorphanol combination across the 24 horses
- •All treatments reduced gastrointestinal motility and heart rate; methadone additionally decreased respiratory rate while all caused transient systolic blood pressure elevations